TB‐5 demonstrates potential as a diagnostic and therapeutic tool due to its high specificity and affinity for bladder cancer tissues, elucidating the significant role of nucleolin in bladder cancer pathology. Here, NUCLEOLIN is linked to urinary bladder carcinoma.